Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Frequently asked questions
What sector does Core Laboratories N.V (CLB) operate in?
Core Laboratories N.V belongs to the Energy sector and operates in the Oil & Gas Equipment & Services industry.
What is Core Laboratories N.V (CLB) current stock price?
As of the latest data, Core Laboratories N.V stock price is $12.06, with a previous close of $12.05. Core Laboratories N.V gained $0.01 in the last trading session, representing a 0.08% increase.
What is Core Laboratories N.V (CLB) current market capitalization?
Core Laboratories N.V market cap is approximately 553.37 million.
What is Core Laboratories N.V (CLB) Earnings Per Share (EPS)?
The trailing EPS is $0.53, and the forward EPS is $0.70.
What is Core Laboratories N.V (CLB) Price-to-Earnings (P/E) ratio?
Core Laboratories N.V current P/E ratio is 22.75, with a forward P/E of 17.15.
What is Core Laboratories N.V (CLB) EBITDA?
Core Laboratories N.V EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 12.98 million.
Does Core Laboratories N.V (CLB) pay dividends?
Yes. Core Laboratories N.V pays quarterly dividends with an annualized yield of 0.33% and an estimated annual payout of $0.04 per share.
When is the next ex-dividend date for Core Laboratories N.V (CLB)?
The next ex-dividend date is scheduled for August 10, 2026.
How did Core Laboratories N.V (CLB) perform in its most recent earnings report?
In the last report (June 30, 2026), Core Laboratories N.V posted an EPS surprise of 37.5% and a revenue surprise of -0.39%.
What is Core Laboratories N.V (CLB) beta (volatility) score?
Core Laboratories N.V has a beta of 1.058, meaning its volatility is roughly in line with the market.
